The DOI matches its Crossref record.
Simultaneous Two‐photon Excitation of Photofrin in Relation to Photodynamic Therapy
Abstract
Photodynamic therapy (PDT), the use of light‐activated drugs (photosensitizers), is an emerging treatment modality for tumors as well as various nononcologic conditions. Single‐photon (1‐γ) PDT is limited by low specificity of the photo‐sensitizer, leading to damage to healthy tissue adjacent to the diseased target tissue. One solution is to use simultaneous two‐photon (2‐γ) excitation with ultrafast pulses of near‐IR light. Due to the nonlinear interaction mechanism, 2‐γ excitation with a focused beam is localized in three dimensions, allowing treatment volumes on the order of femtoliters. We propose that this will be valuable in PDT of age‐related macular degeneration (AMD), which causes blindness due to abnormal choroidal neovasculature and which is currently treated by 1‐γ PDT. Here, Photofrin has been used as the photosensitizer to demonstrate proof‐of‐principle of 2‐γ killing of vascular endothelial cells in vitro. The 2‐γ absorption properties of Photofrin were investigated in the 750–900 nm excitation wavelength range. It was shown that 2‐γ excitation dominates over 1‐γ excitation above 800 nm. The 2‐γ absorption spectrum of Photofrin in the 800–900 nm excitation wavelength range was measured. The 2‐γ cross section decreased from about 10 GM (1 GM = 10‐5 cm 4 s/photon) at 800 nm to 5 GM at 900 nm. Adherent YPEN‐1 endothelial cells were then incubated with Photofrin for 24 h and then treated by PDT at 850 nm where the 1‐γ contribution was negligible. Cell death was monitored with the use of 2‐γ scanning laser microscopy. The light doses required for killing were high (6300 J cm‐2 for ∼50% killing), but 2‐γ cytotoxicity was unequivocally demonstrated. Although Photofrin is, per se, not a good choice for 2‐γ PDT due to its low 2‐γ cross section, this work provides baseline data to guide the development of novel photosensitizers with much higher 2‐γ cross sections (>100 GM), which will be required for 2‐γ PDT of AMD (and other conditions) to be clinically practical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324
Astruc, D., Boisselier, E., & Ornelas, C. (2010) · Chemical Reviews · doi:10.1021/cr900327d · Cited by 1,844
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
Huang, H., Yu, B., Zhang, P., Huang, J., Chen, Y., Gasser, G., Ji, L., & Chao, H. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201507800 · Cited by 449
Metadata
- Authors
- Karotki, A., Khurana, M., Lepock, J. R., & Wilson, B. C.
- Venue
- Photochemistry and Photobiology
- Publisher
- Wiley
- Published
- 2006-03
- Volume
- 82
- Issue
- 2
- Pages
- 443-452
- ISSN
- 0031-8655 (ISSN-L)
- 1751-1097
- OpenAlex
- W2177473133
- Cited by
- 176
- References
- 0
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Simultaneous Two‐photon Excitation of Photofrin in Relation to Photodynamic Therapy. https://app.cochat.ai/papers/10.1562/2005-08-24-ra-657
- The paper
- Karotki, A., Khurana, M., Lepock, J. R., & Wilson, B. C. (2006). Simultaneous Two‐photon Excitation of Photofrin in Relation to Photodynamic Therapy. Photochemistry and Photobiology. https://doi.org/10.1562/2005-08-24-ra-657
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.